Chindex International Inc. is a healthcare company. The Company is engaged in providing health care services in China through the operations of United Family Healthcare and providing medical capital equipment and products through Chindex Medical Ltd. United Family Healthcare is a network of private primary care hospitals and affiliated ambulatory clinics. United Family Healthcare operates in Beijing, Shanghai, Tianjin and Guangzhou markets. Chindex Medical Ltd. is a joint venture company with manufacturing and distribution businesses serving both domestic China and export markets. Operations in Beijing Market include Beijing United Family Hospital main campus, United Family Rehabilitation Hospital and four affiliated satellite clinics. Operations in the Shanghai Market include Shanghai United Family Hospital main campus, two affiliated satellite clinics and two managed clinics. Operations in the Tianjin market include Tianjin United Family Hospital main campus.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Providers & Services
- Sub-Industry: Health Care Facilities
- Symbol: NASDAQ:CHDX
- CUSIP: 16946710
- Web: N/A
- Trailing P/E Ratio:
- P/E Growth:
Frequently Asked Questions for Chindex International (NASDAQ:CHDX)
What is Chindex International's stock symbol?
Chindex International trades on the NASDAQ under the ticker symbol "CHDX."
How were Chindex International's earnings last quarter?
Chindex International Inc (NASDAQ:CHDX) posted its quarterly earnings data on Wednesday, March, 13th. The company reported $0.20 EPS for the quarter. The business earned $43.51 million during the quarter, compared to the consensus estimate of $31.98 million. View Chindex International's Earnings History.
Who are some of Chindex International's key competitors?
Some companies that are related to Chindex International include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Merck KGaA (MKGAY), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), ResMed (RMD), Omnicare (OCR), TESARO (TSRO), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Icon Plc (ICLR), Health Net (HNT), Patheon NV (PTHN), NMC Health PLC (NMC), Catalent (CTLT) and Cotiviti Holdings (COTV).
How do I buy Chindex International stock?
Shares of Chindex International can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chindex International's stock price today?
MarketBeat Community Rating for Chindex International (NASDAQ CHDX)MarketBeat's community ratings are surveys of what our community members think about Chindex International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Chindex International stock can currently be purchased for approximately $23.99.
Consensus Ratings for Chindex International (NASDAQ:CHDX) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Chindex International (NASDAQ:CHDX)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Chindex International (NASDAQ:CHDX)Earnings History by Quarter for Chindex International (NASDAQ CHDX)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/11/2014||Q214||($0.04)||$46.00 million||$55.50 million||View||N/A|
|3/17/2014||Q4||($0.12)||$43.50 million||$48.80 million||View||Listen|
|3/13/2013||Q4 2012||$0.20||$31.98 million||$43.51 million||View||N/A|
Earnings Estimates for Chindex International (NASDAQ:CHDX)
Current Year EPS Consensus Estimate: $0.45 EPS
Dividend History for Chindex International (NASDAQ:CHDX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Chindex International (NASDAQ:CHDX)Insider Trades by Quarter for Chindex International (NASDAQ:CHDX)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/22/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||18||$7.22||$129.96|| |
|12/19/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||100||$7.50||$750.00|| |
|12/16/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||27||$6.42||$173.34|| |
|12/11/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||241||$16.16||$3,894.56|| |
|12/8/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||40||$6.64||$265.60|| |
|12/7/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||624||$10.52||$6,564.48|| |
|12/4/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||100||$5.67||$567.00|| |
|12/3/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||100||$5.37||$537.00|| |
|10/5/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||16||$10.52||$168.32|| |
|9/30/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||2,543,472||$24.00||$61,043,328.00|| |
|9/29/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||1,696||$8.80||$14,924.80|| |
|9/12/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||15,000||$10.43||$156,450.00|| |
|7/19/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||339||$11.50||$3,898.50|| |
|7/18/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||6,308||$23.49||$148,174.92|| |
|7/17/2014||Chase & Co Jpmorgan||Major Shareholder||Sell||3,120||$12.94||$40,372.80|| |
|6/16/2014||Julius Oestreicher||Director||Sell||5,053||$23.68||$119,655.04|| |
|5/15/2014||Julius Oestreicher||Director||Sell||22,500||$23.58||$530,550.00|| |
|4/30/2014||Chase & Co Jpmorgan||Major Shareholder||Buy||22||$12.64||$278.08|| |
|3/19/2014||Elyse Beth Silverberg||EVP||Sell||16,400||$19.20||$314,880.00|| |
Headline Trends for Chindex International (NASDAQ:CHDX)
Latest Headlines for Chindex International (NASDAQ:CHDX)
No headlines for this company have been tracked by MarketBeat.com
Chindex International (CHDX) Chart for Friday, July, 21, 2017